Építés alatt – nem éles oldal
Belépés
Résztvevőt keresFázis nélkül

Thrombectomy in Pulmonary Embolism

A legfontosabb adatok

Ki végzi
University Hospital Plymouth NHS Trust
Hol
Egyesült Királyság1 helyszín, 1 országbanVálassz országot a helyszínekhez
Azonosító
Állapot
Toboroz
Résztvevők
2000 fő, tervezett
Kezdés
2026. máj. 11.
Várható befejezés
2029. dec. 11.
A vizsgálat típusa
Megfigyeléses, 2 csoport
A regiszteradat frissítve
2026. június 25.

Ki vehet részt

MI-összefoglaló

A vizsgálat saját részvételi feltételeiből. Gép olvasta ki az oldalon álló regiszterszövegből, ezért tévedhet. Hogy ki vehet részt, azt a lenti regiszterszöveg és a vizsgálat csapata dönti el.

The trial is looking for adults with a recent blood clot in the lung (pulmonary embolism) of intermediate or high risk, with signs of strain on the heart. It collects data on clot removal through a tube (CAVT thrombectomy) and other treatments.

Életkor
18 years and older
Nem
All sexes can join
A betegség stádiuma
Acute pulmonary embolism confirmed by a CT scan, with symptoms for 14 days or less. It must be intermediate or high risk by European Society of Cardiology guidelines. The CT scan must be from within a two-year period.
Biomarker vagy leletérték
Signs the heart is not working well: blood test or imaging signs of strain on the right side of the heart.

A részvétel fő kizáró okai

  • Known serious, uncontrolled reaction to contrast dyes used in X-ray imaging
  • No CT scan available to check the clot
  • Low-risk pulmonary embolism
  • Taking part in another study of a test drug or device that may affect the results
  • Other medical, social or mental health issues that stop consent or taking part in follow-up

A regiszter feltételei, szó szerint

Mind a 20 feltétel megnézéseKevesebb

Ki vehet részt

  • Clinical signs and symptoms consistent with acute pulmonary embolism with duration of 14 days or less
  • Patients who present with computed tomography confirmed pulmonary embolism
  • Defined as intermediate or high-risk pulmonary embolism (according to European Society of Cardiology guidelines)
  • Date of computed tomography imaging from within a two-year period
  • Patient is greater than or equal to 18 years of age
  • Informed consent obtained
  • Evidence of cardiac dysfunction (either biochemical or imaging features of right heart strain)
  • Clinical signs and symptoms consistent with acute PE with duration of 14 days or less
  • Patients who present with CT confirmed PE
  • Defined as intermediate or high-risk PE (according to ESC guidelines1)
  • Date of CT imaging from within a two-year period
  • Patient is ≥ 18 years of age
  • Informed consent obtained
  • Evidence of cardiac dysfunction (Either biochemical or imaging features of RHS)

Ki nem vehet részt

  • Current participation in another investigational drug or device study that may confound the results of this study. Studies requiring extended follow-up for products that were investigational but have since become commercially available are not considered investigational
  • 1. Known serious, uncontrolled sensitivity to radiographic agents 2. CT not available to evaluate PE 3. Low Risk PE as defined by ESC guidelines1 4. Current participation in another investigational drug or device study that may confound the results of this study. Studies requiring extended follow-up for products that were investigational but have since become commercially available are not considered investigational studies 5. Other medical, social, or psychological conditions that, in the opinion of the Investigator, precludes the patient from appropriate consent, could limit the patient's ability to participate in the study, including compliance with follow-up requirements, or that could impact the scientific integrity of the study
  • Other medical, social, or psychological conditions that, in the opinion of the investigator, preclude the patient from appropriate consent, could limit the patient's ability to participate in the study, including compliance with follow-up requirements, or that could impact the scientific integrity of the study
  • Known serious, uncontrolled sensitivity to radiographic agents
  • Computed tomography not available to evaluate pulmonary embolism
  • Low-risk pulmonary embolism as defined by European Society of Cardiology guidelines

Ez a vizsgálat jelenleg itt érhető el: Egyesült Királyság.

Egy országban van helyszíne. Válassz országot, hogy lásd a helyszíneket.

A vizsgálatról

Mit akar kideríteni a vizsgálat

Pulmonary embolism is a blood clot on the lung, which can cause death or significant reduced quality of life. Sucking the clot out with a special tube (catheter) is a relatively new procedure that can be performed but doesn't have the data required to properly support its use in some patients. We know this procedure works in patients who have no other options and would almost certainly die without intervention. We currently don't know how well this procedure is tolerated, how well it works and what its complications are in patients who are moderately to severely unwell. The National Institute of Clinical Excellence (NICE), an advisory body, suggests more data is required to support its use in patients who are sick or very sick. This registry aims to support this growing evidence base to workout if the treatment is effective and the associated risks that come with using it. We are collecting data about this procedure and other treatments patients get offered to better inform clinicians and researchers.

A vizsgálat 2 csoportja

  • CAVT thrombectomy

    PE with evidence of right heart strain and thrombectomy with 16Fr CAVT

  • PE with evidence of right heart strain

Kérdések a vizsgálat csapatának

  1. Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
  2. Megtérítik az utazási költséget?
  3. Megtarthatom a saját orvosomat?
  4. Mi történik, ha ki akarok lépni?

Contact the study team: see the registry record → Contacts and Locations

Oldal nyomtatása az orvosomnak

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
Hivatalos cím
Prospective Observational Study to Evaluate the Use of Computer-Aided Vacuum Thrombectomy Within the Context of Intermediate and High-Risk Pulmonary Embolism
MI-összefoglaló
A vizsgálat saját részvételi feltételeiből. Gépi kiolvasás: 2026. november 15.
A regiszteradat frissítve
2026. június 25.